Hola, que podries dir-me de la teràpia electroconvulsiva i l'estigma

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.

Posted: 6 May 2026Updated: 6 May 2026 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX

Electroconvulsive therapy (ECT) is a well-established, effective somatic treatment primarily used in psychiatry for severe depression and other psychiatric conditions such as bipolar disorder and schizophrenia, demonstrating faster and sometimes superior clinical responses compared to pharmacotherapy , . Despite its efficacy and rapid action, ECT remains notably underutilized, largely due to persistent stigma and misconceptions surrounding its use .



Stigma associated with ECT is multifaceted, encompassing societal, patient, and provider-level biases. Negative attitudes towards ECT are often driven by historical misuse, misleading media portrayals, and lack of accurate knowledge concerning the procedure, its efficacy, and safety profile . This stigma creates significant barriers to access, with patients and providers sometimes viewing ECT as a 'last-resort' or coercive treatment despite contemporary guidelines recommending it as a first-line option in specific urgent clinical situations .



Patient knowledge deficits contribute substantially to stigmatizing attitudes. For example, patients with bipolar disorder were found to have incomplete understanding of ECT's mechanisms, treatment cycles, and neurobiological benefits, leading to predominantly negative attitudes despite a moderate willingness to consider ECT when adequately informed . Improving knowledge is key: greater patient understanding positively correlates with improved attitudes and increased willingness to accept ECT . Similarly, tailored educational interventions for healthcare providers, such as interactive workshops focusing on ECT referral assessment and stigma reduction, have demonstrated increased confidence in addressing stigma and making appropriate referrals for depressed patients .



Provider attitudes also shape access to ECT. Misconceptions about side effects, especially cognitive risks, and incomplete training on ECT indications contribute to reluctance in recommending this treatment . Variability in ECT education worldwide, including limited training hours and inconsistent clinical exposure for psychiatry trainees, exacerbates this issue and perpetuates stigma within clinical practice . In India, for example, research shows that outdated equipment, inconsistent monitoring, and regulatory hurdles compound stigma and service inequality, highlighting systemic as well as educational challenges .



Addressing stigma requires a multifaceted approach. Educational programs that engage both emotions and cognitive understanding — using patient stories, interactive case discussions, and reflective practice — have proven effective in reducing stigma and improving knowledge and attitudes among trainees and providers . Patient-focused educational initiatives tailored to address specific concerns, dispel myths, and highlight safety and efficacy can shift negative perceptions, notably by clarifying misconceptions about side effects and procedure details . Incorporating patient testimonials and culturally sensitive communication further fosters acceptance .



System-level factors also influence stigma and access. Regulatory frameworks, such as the Indian Mental Healthcare Act 2017, imposing restrictions on unmodified ECT and requiring additional oversight, while ethically motivated, can unintentionally limit availability, especially in resource-limited settings, and accentuate stigma by casting ECT as risky or exceptional . Additionally, lack of infrastructure, anesthesia support, and disparities in healthcare provision, particularly in rural or underserved areas, affect equitable access and perpetuate stigma .



Overall, stigma around ECT arises from a complex interplay among knowledge gaps, cultural attitudes, media-driven misconceptions, provider education deficits, and systemic barriers. Addressing these challenges through targeted education, improved training, transparent communication, and policy adjustments is essential to normalize ECT as a safe, effective treatment, reduce stigma, and optimize access and outcomes for patients with severe psychiatric illnesses .

Educational content only. Always verify information and use clinical judgement.